Publication | Closed Access

Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods

Translational MedicineEngineeringPharmacokinetic ModelingSelective Sglt2 InhibitorMedicineAllometric ScalingTranslational PredictionRational Drug DesignTranslational ResearchPharmacotherapyPharmacodynamic ModelingSystems BiologyPharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsDrug Discovery